Shanghai Titan Scientific Hits Day Low at CNY 18.88 Amid Price Pressure

Shanghai Titan Scientific Co., Ltd. experienced significant activity on March 23, 2026, with the stock declining by 7.28% and reaching an intraday low of CNY 18.88. This performance stands in contrast to the broader market, as the China Shanghai Composite index fell by 3.63% on the same day. Over the past week, Shanghai Titan has seen a steep decline of 16.92%, and its performance over the past month has dropped by 20.78%. Year-to-date, the stock is down 13.73%, while its one-year performance shows a decrease of 17.06%, significantly underperforming the China Shanghai Composite, which has gained 13.33% during the same period. The company's financial metrics indicate ongoing challenges, with net sales declining by 7.31% and a pre-tax profit of CNY -1.67 million, reflecting a 60.06% decrease. Additionally, the company has reported negative results for the last seven consecutive quarters, highlighting a trend of poor financial performance. With a market capitalization of CNY 3,965 million, Shanghai Titan operates within the pharmaceuticals and biotechnology sector, but its long-term growth prospects appear limited, as evidenced by a return on equity of -0.17%.